Exousia Bio, Inc. Increase (Decrease) in Accounts Receivable
Exousia Bio, Inc. (LMMY) reported Increase (Decrease) in Accounts Receivable of -$11.50 thousand for the 12-month period ending 2025-05-31, per its 10-K filed 2025-10-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2025-10-17
- Exousia Bio, Inc. increase (decrease) in accounts receivable for the quarter ending 2024-05-31 was $3.75K.
- Exousia Bio, Inc. increase (decrease) in accounts receivable for the quarter ending 2024-02-29 was $3.88K.
- Exousia Bio, Inc. increase (decrease) in accounts receivable for the quarter ending 2023-05-31 was $0.00.
- Exousia Bio, Inc. increase (decrease) in accounts receivable for the quarter ending 2023-02-28 was $0.00.
- Exousia Bio, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$11.50K, a 200.00% decline from fiscal 2024.
- Exousia Bio, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $11.50K.
- Exousia Bio, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2025-05-31 | -$11.50K 10-K · filed 2025-10-17 | |||
| 2024-05-31 | $3.75K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-17 | $7.63K derived: sum of 2 quarters · filed 2025-10-17 | $11.50K 10-K · filed 2025-10-17 | |
| 2024-02-29 | $3.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-15 | $7.75K 10-Q · filed 2024-04-15 | ||
| 2023-11-30 | $3.88K 10-Q · filed 2024-01-16 | |||
| 2023-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-30 | $0.00 derived: sum of 2 quarters · filed 2024-08-30 | $0.00 10-K · filed 2024-08-30 | |
| 2023-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-15 | $0.00 10-Q · filed 2024-04-15 | ||
| 2022-11-30 | $0.00 10-Q · filed 2024-01-16 |